Vascular Behçet syndrome: from pathogenesis to treatment

A Bettiol, F Alibaz-Oner, H Direskeneli… - Nature Reviews …, 2023 - nature.com
Behçet syndrome is a rare, chronic inflammatory disease of unknown aetiopathogenesis,
most commonly presenting with mucocutaneous and ocular manifestations. Vascular …

Thrombosis in vasculitis: from pathogenesis to treatment

G Emmi, E Silvestri, D Squatrito, A Amedei, E Niccolai… - Thrombosis journal, 2015 - Springer
In recent years, the relationship between inflammation and thrombosis has been deeply
investigated and it is now clear that immune and coagulation systems are functionally …

[HTML][HTML] Behçet's disease as a model of venous thrombosis

M La Regina, AY Gasparyan, F Orlandini… - The open …, 2010 - ncbi.nlm.nih.gov
Behçet's disease (BD) is a chronic inflammatory disease of unknown aetiology characterized
by recurrent oral, genital aphthous ulcerations, uveitis, skin lesions and other multisystem …

Increased levels of asymmetric dimethylarginine (ADMA) in patients with ankylosing spondylitis

I Sari, L Kebapcilar, A Alacacioglu, O Bilgir… - Internal …, 2009 - jstage.jst.go.jp
Objective Endothelial dysfunction is present in ankylosing spondylitis (AS). However, the
etiology of events is still unclear. The aim of the present study was to investigate whether …

Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media …

M Yuksel, A Yildiz, M Oylumlu, FM Turkcu, MZ Bilik… - Clinical …, 2016 - Springer
The etiology of Behçet's disease (BD) has not been fully elucidated. However,
immunological and environmental factors, endothelial dysfunction (ED), and genetic …

Endothelial dysfunction and altered coagulation as mediators of thromboembolism in Behçet disease

NV Butta, I Fernández-Bello… - … in thrombosis and …, 2015 - thieme-connect.com
Behçet disease (BD) is a rare multisystem, inflammatory disease of unknown etiology with
vascular involvement and associated thrombogenicity. This review aims to describe the …

Anti-inflammatory polymeric nanoparticles based on ketoprofen and dexamethasone

E Espinosa-Cano, MR Aguilar, Y Portilla, DF Barber… - Pharmaceutics, 2020 - mdpi.com
Polymeric nanoparticles that combine dexamethasone and naproxen reduce inflammation
and synergistically inhibit Interleukin-12b (Il12b) transcription in macrophages. This effect …

Meta-analysis of asymmetric dimethylarginine concentrations in rheumatic diseases

GL Erre, AA Mangoni, F Castagna, P Paliogiannis… - Scientific Reports, 2019 - nature.com
Raised circulating concentrations of asymmetric dimethylarginine (ADMA), an endogenous
inhibitor of nitric oxide synthase (NOS), have been reported in several rheumatic diseases …

[PDF][PDF] Evaluation of atherogenic laboratory markers in Behçet's disease patients with vascular involvement

Ç Yücel, A Omma, E Sertoğlu, S Sezer… - Archives of Medical …, 2020 - termedia.pl
Results hsCRP, TNF-α, homocysteine, IMA, apoA1, apoB, HDL, Lp-pla2 and ESR levels in
patient and control groups were significantly different (p< 0.001, p= 0.001, p< 0.001, p< …

Markers of endothelial dysfunction and evaluation of vascular reactivity tests in Behçet disease

P Ozuguz, AA Karabulut, M Tulmac, U Kisa… - …, 2014 - journals.sagepub.com
We assessed endothelial dysfunction (ED) in patients with Behcet disease (BD; n= 40) and
healthy controls (n= 20). Serum lipid, homocysteine, asymmetric dimethylarginine (ADMA) …